Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
1. Arechin
2. Chingamin Phosphate
3. Chloroquine Bis(dihydrogenphosphate) Dihydrate
4. Chloroquine Diphosphate
5. Chloroquine Diphosphate, (+)-isomer
6. Chloroquine Diphosphate, (+-)-isomer
7. Chloroquine Diphosphate, (-)-isomer
8. Delagil
9. Khingamin Phosphate
10. N(4)-(7-chloro-4-quinolinyl)-n(1),n(1)-diethyl-1,4-pentanediamine, Phosphate (1:2)
11. Resochin
12. Unspecified Phosphate Of Chloroquine Diphosphate
1. Chloroquine Diphosphate
2. 50-63-5
3. Resochin
4. Arechin
5. Aralen Phosphate
6. Chingamin Phosphate
7. Chloroquine Bis(phosphate)
8. Chloroquine Diphosphate Salt
9. Avloclor
10. Delagil
11. Chloroquine (phosphate)
12. Khingamin
13. Miniquine
14. Tanakan
15. Tanakene
16. Aralen Diphosphate
17. Gontochin Phosphate
18. N4-(7-chloroquinolin-4-yl)-n1,n1-diethylpentane-1,4-diamine Bis(phosphate)
19. Chloroquin Diphosphate
20. Nsc 14050
21. Ipsen 225
22. Chloroquinediphosphate
23. Mfcd00069852
24. 3377 Rp
25. 50-63-5 (diphosphate)
26. Sn 7,618
27. Nsc-14050
28. 6e17k3343p
29. Sn-7618
30. Wr-1522
31. Chingaminum
32. Alermine
33. H-stadur
34. Dsstox_cid_24681
35. Dsstox_rid_80393
36. Dsstox_gsid_44681
37. 1,4-pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-n(sup 1),n(sup 1)-diethyl-, Phosphate (1:2)
38. Chlorochin Diphosphate
39. Tanakan (antimalarial)
40. 4-n-(7-chloroquinolin-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;phosphoric Acid
41. Dl-chloroquine Diphosphate
42. Ccris 1554
43. Sr-01000075548
44. Einecs 200-055-2
45. Wr 1522
46. Chloroquine Dihydrogen Phosphate (1:2)
47. Unikinon
48. Ai3-14952
49. Unii-6e17k3343p
50. Chloroquine Phosphate [usp:ban]
51. Chloroquindiphosphat
52. Chloroquini Phosphas
53. Prestwick_867
54. Aralen (tn)
55. Cas-50-63-5
56. Ncgc00015256-01
57. 7-chlor-4-(4-(diaethylamino)-1-methylbutylamino)-chinolindiphosphat [german]
58. 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline Phosphate (1:2)
59. N4-(7-chloro-4-quinolinyl)-n1,n1-dimethyl-1,4-pentanediamine Diphosphate Salt
60. Chloroquine Diphosphate,(s)
61. 1,4-pentanediamine, N4-(7-chloro-4-quinolinyl)-n1,n1-diethyl-, Phosphate (1:2)
62. N(4)-(7-chloro-4-quinolinyl)-n(1),n(1)-diethyl-1,4-pentanediamine, Phosphate (1:2)
63. 1,4-diamine Bis(phosphate)
64. Chloroquine Phosphate (usp)
65. Schembl40827
66. Chembl58510
67. Spectrum1500179
68. Chloroquine Diphosphate, Sulfate
69. Dtxsid7044681
70. Hms501e06
71. Hms1569n17
72. Hms1920o05
73. Hms2091c16
74. Hms2096n17
75. Hms3260l14
76. Hms3713n17
77. Bcp31956
78. Chloroquine Diphosphate [mi]
79. Tox21_110115
80. Tox21_202838
81. Tox21_500296
82. 7-chlor-4-(4-(diaethylamino)-1-methylbutylamino)-chinolindiphosphat
83. Ccg-39643
84. Chloroquine Phosphate [vandf]
85. S4157
86. Chloroquine Phosphate [mart.]
87. Akos004910410
88. Chloroquine Phosphate [usp-rs]
89. Chloroquine Phosphate [who-dd]
90. Chloroquine Phosphate [who-ip]
91. N4-(7-chloro-4-quinolyl)-n1,n1-diethyl-pentane-1,4-diamine; Phosphoric Acid
92. Quinoline, 7-chloro-4-(4-diethylamino-1-methyl-butylamino)-, Diphosphate
93. Tox21_110115_1
94. Cs-3811
95. Dt-0015
96. Lp00296
97. 1,4-pentanediamine, N4-(7-chloro-4-quinolinyl)-n',n'-diethyl-, (+-)-, Phosphate (1:2)
98. Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-, Phosphate (1:2)
99. Ncgc00015256-12
100. Ncgc00093746-01
101. Ncgc00093746-02
102. Ncgc00093746-03
103. Ncgc00260384-01
104. Ncgc00260981-01
105. Ac-12463
106. Chloroquine Phosphate [green Book]
107. Hy-17589
108. Sy021941
109. Chloroquine Phosphate [orange Book]
110. Chloroquine Phosphate [ep Monograph]
111. Chloroquini Phosphas [who-ip Latin]
112. Db-051808
113. Chloroquine Diphosphate Salt, Solid, >=98%
114. Chloroquine Phosphate [usp Monograph]
115. Eu-0100296
116. Ft-0602804
117. C 6628
118. D02125
119. D70732
120. 069c852
121. A828213
122. N4-(7-chloroquinolin-4-yl)-n1,n1-diethylpentane-
123. Sr-01000075548-1
124. Sr-01000075548-3
125. Sr-01000075548-5
126. Q27264629
127. F2173-1139
128. 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline Phosphate
129. 7-chloro-4-[4-(diethylamino)-1-methylbutylamino]quinoline Bis(phosphate)
130. 7-chloro-4-[4-(diethylamino)-1-methylbutylamino]quinoline Diphosphate
131. Chloroquine Phosphate, United States Pharmacopeia (usp) Reference Standard
132. N4-(7-chloro-4-quinolyl)-n1,n1-diethyl-1,4-pentanediamine Diphosphate
133. 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline Phosphate (1:2).
134. Chloroquine Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
135. Chloroquine Phosphate;aralen Phosphate;7-chloro-4-((4 Inverted Exclamation Mark -diethylamino-1-methylbutyl)amino)quinolinediphosphate
Molecular Weight | 515.9 g/mol |
---|---|
Molecular Formula | C18H32ClN3O8P2 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 8 |
Exact Mass | 515.1353167 g/mol |
Monoisotopic Mass | 515.1353167 g/mol |
Topological Polar Surface Area | 184 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 359 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Chloroquine phosphate |
Drug Label | Chloroquine phosphate, USP is a 4-aminoquinoline compound for oral administration. It is a white crystalline powder; odorless; has a bitter taste, and is discolored slowly on exposure to light. It is freely soluble in water, practically insoluble in... |
Active Ingredient | Chloroquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 300mg base; eq 150mg base |
Market Status | Prescription |
Company | Ipca Labs; Natco Pharma; Hikma Pharms; Impax Labs |
2 of 2 | |
---|---|
Drug Name | Chloroquine phosphate |
Drug Label | Chloroquine phosphate, USP is a 4-aminoquinoline compound for oral administration. It is a white crystalline powder; odorless; has a bitter taste, and is discolored slowly on exposure to light. It is freely soluble in water, practically insoluble in... |
Active Ingredient | Chloroquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 300mg base; eq 150mg base |
Market Status | Prescription |
Company | Ipca Labs; Natco Pharma; Hikma Pharms; Impax Labs |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Filaricides
Pharmacological agents destructive to nematodes in the superfamily Filarioidea. (See all compounds classified as Filaricides.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3926
Submission : 1980-07-31
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6425
Submission : 1986-06-11
Status : Inactive
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-06-21
Pay. Date : 2019-06-14
DMF Number : 33067
Submission : 2019-02-20
Status : Active
Type : II
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-8080
Start Marketing Date : 2018-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-10-25
Pay. Date : 2013-07-15
DMF Number : 9235
Submission : 1991-07-02
Status : Active
Type : II
Certificate Number : R1-CEP 2005-177 - Rev 01
Issue Date : 2021-08-05
Type : Chemical
Substance Number : 544
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm :
NDC Package Code : 57451-1116
Start Marketing Date : 2012-05-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-09
Pay. Date : 2019-09-27
DMF Number : 34130
Submission : 2019-09-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10472
Submission : 1993-09-10
Status : Inactive
Type : II
Date of Issue : 2022-10-27
Valid Till : 2025-07-22
Written Confirmation Number : WC-0167
Address of the Firm :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6425
Submission : 1986-06-11
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3926
Submission : 1980-07-31
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-10-25
Pay. Date : 2013-07-15
DMF Number : 9235
Submission : 1991-07-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-21
Pay. Date : 2019-06-14
DMF Number : 33067
Submission : 2019-02-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10472
Submission : 1993-09-10
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-09
Pay. Date : 2019-09-27
DMF Number : 34130
Submission : 2019-09-20
Status : Active
Type : II
Chloroquine Phosphate (BP/ Ph.Eur/USP)
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm : Sejavta, Ratlam, Madhya Pradesh
Date of Issue : 2022-10-27
Valid Till : 2025-07-22
Written Confirmation Number : WC-0167
Address of the Firm : Unit No.1, Plot No.187, IInd Phase, GIDC Vapi-396195, Dist-Valsad, India
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm : Mekaguda (V) kothur (M) Mahabood nagar Dist, Telangana State India
NDC Package Code : 73377-214
Start Marketing Date : 2022-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 57451-1116
Start Marketing Date : 2012-05-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-8080
Start Marketing Date : 2018-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68022-7057
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Atman Pharmaceuticals is a fully integrated pharmaceutical company that has distinguished itself as a leader in Bulk Drugs (API) marketing both domestically in India and overseas. ...
About the Company : BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-info...
About the Company : Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates ...
About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pha...
About the Company : Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an in-house R&D lab reco...
About the Company : Micro Orgo Chem is a pharmaceutical establishment, manufacturing niche Active Pharmaceutical Ingredients (API). Founded in 1992, we have a mission of providing high quality drugs t...
About the Company : NATCO PHARMA LIMITED was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 e...
About the Company : The technology of production of artemisinin and its derivatives is based on the use of cultivation of annual wormwood cells and extraction of artemisinin and artemisinic acid. Qual...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products
Dosage Form : Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products
Pharmacopoeia Ref : Ph. Eur., USP: Povidone; JPE: ...
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Dosage Form : Tablet
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Tablet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Dosage Form : Tablet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Povidone
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?